Navigation Links
Transgenomic, Inc. Enhances FAMILION® Genetic Test Offerings
Date:5/4/2011

OMAHA, Neb., May 4, 2011 /PRNewswire/ -- Transgenomic, Inc. (OTC/BB: TBIO) announced a significant enhancement to its FAMILION Brugada Syndrome (BrS) test panel at the 2011 Heart Rhythm Society meeting in San Francisco. The expanded panel includes analysis of 9 genes and broadens the test indication to include other J-wave syndromes, including Early Repolarization Syndrome.  

"The addition of two newly identified J-wave syndrome genes, KCND3 and KCNJ8, reflects Transgenomic's commitment to translating new genetic advances into clinical practice," said Benjamin Salisbury, Ph.D., Vice President of Clinical Genetics at Transgenomic. "The renaming of the FAMILION BrS Test to the FAMILION BrS/J-Wave Test acknowledges the growing understanding that Brugada Syndrome is part of a spectrum of disorders with similar clinical presentations and a shared genetic basis that have been collectively termed J-wave syndromes."

The introduction of a newly enhanced test for BrS and other J-wave syndromes marks the fourth significant test launched or expanded in the FAMILION family of genetic tests over the past 6 months.  The comprehensive and evolving menu of FAMILION genetic tests, as well as participation in primary research, demonstrates the Company's commitment to setting the standard for cardiac genetic testing and its support of the clinical community.

"We are excited to see the continued interest and growth in the FAMILION line of cardiac genetic tests," said Craig Tuttle, CEO of Transgenomic. "The integration of the FAMILION brand into the Transgenomic family has strengthened our outlook and continues to position the company for greater success in the future."

About the FAMILION Tests

The FAMILION family of tests detects genetic mutations that can cause cardiac channelopathies, cardiomyopathies, and other
'/>"/>

SOURCE Transgenomic, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Transgenomic, Inc. Presentations to Describe High-Sensitivity Detection of Cancer Biomarkers at the 2011 American Association for Cancer Research Meeting
2. Transgenomic, Inc. Reports Third Quarter 2009 Results
3. Transgenomic, Inc. Reports Second Quarter 2009 Results
4. Transgenomic, Inc. Announces Appointment of New Board Members
5. Transgenomic, Inc. Reports First Quarter 2009 Results
6. Transgenomic, Inc. Reports Fourth Quarter and Fiscal Year 2008 Results
7. Transgenomic, Inc. Reports Third Quarter 2008 Results
8. Nanocrystal doping developed by Hebrew University researchers enhances semiconductor nanocrystals
9. Transgenomic Announces Discovery of a Novel Technique Which Enhances Analytic Sensitivity of Standard Sanger Sequencing to 1%
10. DuPont Enhances its PROaccess℠ Business Strategy Through Acquisitions
11. Caliper Enhances Strategic Focus and Increases Growth Capital with Sale of Product Lines to Biotage
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... 17, 2014 This report is ... Tubing industry. For an overview analysis, the report ... industry chain structure, industry overview, policy analysis, and ... industry has witnessed rapid development with key ... acquisitions. This report mentions quartz tubing upstream raw ...
(Date:12/17/2014)... December 17, 2014 Audacity, a leading ... and member of the Huntsworth Health Group, is proud ... executive team. In her role, Gonzales will serve as ... are incredibly honored to welcome a talent of Jamie’s ... CEO, Gaëtan Fraikin. “She is a proven healthcare innovation ...
(Date:12/17/2014)... CASI Pharmaceuticals, Inc. (Nasdaq: CASI ... and commercialization of innovative therapeutics addressing cancer and other ... primary commercial focus on China , ... C meeting with the U.S. Food and Drug Administration ... February 2015.  During this meeting the Company will seek ...
(Date:12/15/2014)... 2014 METTLER TOLEDO is pleased ... ParticleView V19 with PVM technology , is ... vision and measurement tool continuously captures high-resolution images ... V19 then automatically prepares a report pairing the ... and concentration changes. This compelling blend of high ...
Breaking Biology Technology:2020 Quartz Tubing Market: Global Development & Forecasts Analysis Now at DeepResearchReports.com 2Audacity Welcomes Healthcare Communications Expert Jamie Gonzales as Senior Vice President of Client Services 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5New Real-Time In Situ Probe-Based Video Microscope from METTLER TOLEDO 2
... law firm of Finkelstein,Thompson LLP announces that a class ... Court for the Southern District of New York on,behalf ... GPC Biotech AG,("GPC Biotech" or the "Company") (Nasdaq: ... inclusive (the "Class Period"). Finkelstein Thompson LLP,is investigating similar ...
... BioSciences Inc.,(AMEX: YMI , TSX: YM, AIM: ... differentiated products for patients worldwide,today announced that Oncoscience ... of the humanized EGFR-targeting monoclonal antibody,nimotuzumab, has advised ... commence in Europe. - A ...
... -- Sinovac Biotech Ltd. (Amex:,SVA), a leading ... shareholders today that the Annual General Meeting ... been postponed due the geographical,nature of its ... of,proxy materials. The Company is currently working ...
Cached Biology Technology:Finkelstein Thompson LLP Announces GPC Biotech AG Investigation 2YM BIOSCIENCES', EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER 2YM BIOSCIENCES', EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER 3YM BIOSCIENCES', EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER 4Sinovac Announces Postponement of Annual General Meeting 2
(Date:12/5/2014)... MOUNTAIN VIEW, Calif. , Dec. 4, 2014 ... and safety has boosted investments in new testing ... products has also given rise to a range ... driven by the requirements of Generation Y, which ... digital technologies. As a result, product development strategies ...
(Date:12/4/2014)... Dec. 3, 2014  Crossmatch™, a leading provider ... its DigitalPersona ® Pro Enterprise software and ... deployed throughout First Bank branch locations in ... Carolina and Virginia. First Bank, a progressive ... Pines, North Carolina , selected the Crossmatch ...
(Date:12/3/2014)... , Dec. 2, 2014 As part ... readers, Inception Technologies is pleased to announce the release ... for customers to collect the workforce data that they ... that have been left by existing readers. Many such ... interface, connectivity and modern technology. Older models force users ...
Breaking Biology News(10 mins):Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3Inception Technologies to Release New Biometric Reader 2
... Stanford University research team has been awarded $6.27 million ... to be more energy efficient at home. The funding, ... U.S. Department of Energy,s Advanced Research Projects Agency-Energy (ARPA-E), ... come from Stanford and the California Energy Commission. ...
... skeleton made of segments, the vertebrae. During development of the embryo, ... head-end to the tail-end: the first segments to be added become ... ribs and the last ones the vertebra located in the tail ... it is crucial that, on the one hand, each segment, as ...
... October 27 2009 - The Government of Nepal announced today ... Landscape by 900 sq km, which will increase critical habitat ... at the inaugural session of the Kathmandu Global Tiger Workshop. ... government would establish a National Tiger Conservation Authority as well ...
Cached Biology News:Stanford researchers awarded $6.27 million to study energy efficiency and human behavior 2The skeleton: Size matters 2Nepal expands critical tiger habitat 2
... Reagent A - Fixation medium Reagent B ... intended for fixing cells in suspension with ... with Reagent B. This procedure gives antibodies ... morphological scatter characteristics of the cells intact. ...
... polyclonal to JNK1 (phospho T183 + Y185) ... domain containing phosphorylated T183/Y185. Reactivity / Specificity ... yet tested in other species. Background Information ... the ERK, JNK, and p38 kinases. The members ...
... Dako Target Retrieval Solution, pH 9 (x ... buffer, pH 9, intended for heat-induced target ... is well-suited for use on formalin-fixed, paraffin-embedded ... with 0.01 mol/L citrate buffer, pH 6, ...
... been designed to provide a thin film-like barrier when ... slide. This barrier creates the proper surface tension ... on the slide. PAP Pen contains a special ... It can be removed, if desired, by xylene after ...
Biology Products: